Ustekinumab becomes second biologic approved for PsA in kidsAugust 3, 2022Rare DiseasesMusculoskeletal Disorders
No more ‘escape hatch’: Post Roe, new worries about meds linked to birth defectsJune 29, 2022DermatologyGastroenterologyMusculoskeletal Disorders
Biomarkers may help to predict persistent oligoarticular JIAJune 17, 2022Rare DiseasesMusculoskeletal Disorders
FDA expands indication for spinal muscular atrophy drugMay 31, 2022Rare DiseasesNeurologyMusculoskeletal Disorders
Pfizer COVID vaccine performs well in youth with rheumatic diseasesMay 17, 2022COVID-19 UpdatesVaccinesMusculoskeletal Disorders
Myositis guidelines aim to standardize adult and pediatric careMay 13, 2022Musculoskeletal DisordersRare DiseasesNeurologyOncologyGastroenterologyDermatologyPulmonology
Prior authorizations delay TNF inhibitors for children with JIAMay 11, 2022Musculoskeletal DisordersRare Diseases
Children with RMDs not at high risk for severe COVID-19, study findsApril 13, 2022COVID-19 UpdatesMusculoskeletal DisordersInfectious Diseases
JIA disease activity, disability linked to social factorsApril 7, 2022Rare DiseasesMusculoskeletal Disorders
Virtual and in-person pediatric visits get similar family ratingsMarch 29, 2022Business of MedicineMusculoskeletal Disorders
Eighteen-year study shows inconsistencies in treating, classifying JIAFebruary 15, 2022Musculoskeletal DisordersAdolescent Medicine
CDC, AAP issues new guidelines to better define developmental milestonesFebruary 14, 2022NeurologyMusculoskeletal Disorders
